A local anesthetic, ropivacaine, suppresses activated microglia via a nerve growth factor-dependent mechanism and astrocytes via a nerve growth factor-independent mechanism in neuropathic pain
2011

Ropivacaine Reduces Pain by Targeting Brain Cells

Sample size: 8 publication Evidence: high

Author Information

Author(s): Toda Shigeru, Sakai Atsushi, Ikeda Yumiko, Sakamoto Atsuhiro, Suzuki Hidenori

Primary Institution: Nippon Medical School

Hypothesis

Ropivacaine may alleviate neuropathic pain by suppressing activated microglia and astrocytes through nerve growth factor mechanisms.

Conclusion

Ropivacaine provides prolonged pain relief by inhibiting microglial activation in a nerve growth factor-dependent manner and astrocyte activation in a nerve growth factor-independent manner.

Supporting Evidence

  • Ropivacaine significantly reduced thermal hyperalgesia in CCI rats.
  • The analgesic effect of ropivacaine persisted for at least 2 days after treatment.
  • Ropivacaine suppressed the activation of microglia and astrocytes in the spinal cord.

Takeaway

Ropivacaine is a medicine that helps reduce pain by calming down certain brain cells that get too active when we are hurt.

Methodology

The study involved repetitive epidural administration of ropivacaine in a rat model of neuropathic pain, measuring pain response and glial cell activation.

Participant Demographics

Male Sprague-Dawley rats, weighing 220-300 g.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1744-8069-7-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication